Description |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Searle Pharma |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Martin Dow |
Ondansetron 8mg/4ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Bevacizumab 400mg/16ml |
Product Type |
Product Size |
Tablets |
30'S |
Product Company |
PMS Pharma |
Exemastane 25mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Pertuzumab 420mg/14ml |
Product Type |
Product Size |
Tablet |
60'S |
Product Company |
Pharma Solution |
Erlotinib 150mg |
Content | Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. | Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. | "
Bevacizumab is a type of targeted cancer drug treatment. It is also known as Avastin. It is a treatment for a number of different cancer types. | Exemestane is used to treat early breast cancer in women who have experienced menopause ('change of life'; end of monthly menstrual periods). | "
Pertuzumab is a monoclonal antibody. . Monoclonal antibodies work by attaching to proteins on or in cancer cells. Human epidermal growth factor 2 (HER2) is a protein that makes cells grow and divide. | Erlotinib is an EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers. |
Reviews
There are no reviews yet.